Adrenal Cortex Hormones
"Adrenal Cortex Hormones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D000305
|
| MeSH Number(s) |
D06.472.040
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Adrenal Cortex Hormones".
Below are MeSH descriptors whose meaning is more specific than "Adrenal Cortex Hormones".
This graph shows the total number of publications written about "Adrenal Cortex Hormones" by people in this website by year, and whether "Adrenal Cortex Hormones" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 1 | 2 | | 1999 | 1 | 2 | 3 | | 2001 | 2 | 3 | 5 | | 2002 | 5 | 4 | 9 | | 2003 | 3 | 1 | 4 | | 2004 | 0 | 8 | 8 | | 2005 | 1 | 8 | 9 | | 2006 | 4 | 3 | 7 | | 2007 | 6 | 6 | 12 | | 2008 | 6 | 13 | 19 | | 2009 | 5 | 5 | 10 | | 2010 | 6 | 10 | 16 | | 2011 | 3 | 9 | 12 | | 2012 | 5 | 11 | 16 | | 2013 | 4 | 5 | 9 | | 2014 | 7 | 4 | 11 | | 2015 | 13 | 8 | 21 | | 2016 | 12 | 12 | 24 | | 2017 | 5 | 6 | 11 | | 2018 | 12 | 13 | 25 | | 2019 | 12 | 6 | 18 | | 2020 | 11 | 15 | 26 | | 2021 | 7 | 14 | 21 | | 2022 | 1 | 14 | 15 | | 2023 | 1 | 19 | 20 | | 2024 | 3 | 9 | 12 | | 2025 | 10 | 6 | 16 | | 2026 | 3 | 2 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Adrenal Cortex Hormones" by people in Profiles.
-
Palmsten K, Seburg EA, Ziegenfuss JY, Vazquez-Benitez G, JaKa MM, Chambers CD, Avalos LA, Kharbanda EO. Provider Perspectives to Inform a Patient-Facing Decision Aid on Oral Corticosteroid Use During Pregnancy and Evaluation of the Aid. Pharmacoepidemiol Drug Saf. 2026 Jul; 35(7):e70413.
-
Huang SP, Su CC, Nethery R, Josey K, Bates B, Robinson D, Gandhi P, Rua M, Parthasarathi A, Setoguchi S, Yang YK. A Drug-Environment Interaction Between PM2.5 Concentration and Corticosteroid Use on Cardiovascular and Thromboembolic Events in Older Adults. Pharmacoepidemiol Drug Saf. 2026 Jul; 35(7):e70414.
-
Andoh AA, Tanverdi MS, Shapiro DJ, Lipshaw MJ, Cushing AM, Olsen CS, Meeks HD, Morris K, Leonard JC, Zorc JJ. Variations in Corticosteroids Used for Asthma Exacerbations in the Pediatric Emergency Department: A Pediatric Emergency Care Applied Research Network Registry Study. J Allergy Clin Immunol Pract. 2026 Jun; 14(6):1363-1372.e2.
-
Sessions J, Bauer M, Menard-Katcher C, Nguyen N. Advances in Management of Eosinophilic Esophagitis in Pediatrics. Paediatr Drugs. 2026 May; 28(3):269-283.
-
Patil MA, Matter BA, Santana C, Kompella UB. Interspecies scaling of suprachoroidal drug delivery using ocular geometry and drug physicochemical properties. Sci Rep. 2026 Jan 16; 16(1):4502.
-
Navanandan N, Hagopian E, Brinton JT, Tanverdi M, Edid A, Linn C, Sulbaran H, Florin TA, Mistry RD, Seibold MA, Szefler SJ, Liu AH, Hamlington KL. Oscillometry Measures the Response to Acute Asthma Therapy in the Pediatric Emergency Department. Ann Am Thorac Soc. 2025 12; 22(12):1900-1910.
-
Atkinson MA, Chang JC, Davies AG, Maltenfort M, Luna IY, Scobell R, Mitsnefes M, Stotter BR, Dharnidharka VR, Dixon BP, Flynn JT, Gluck C, Kallash M, Smoyer WE, Razzaghi H, Bailey LC, Furth SL, Forrest CB, Denburg MR, Wenderfer SE. Using a multi-institutional pediatric learning health system to characterize induction therapy for incident lupus nephritis in children. Pediatr Nephrol. 2026 Apr; 41(4):1045-1053.
-
Hayde N, Blanchette E, Bock M, Blydt-Hansen T. Outcomes of Steroid Based Versus Steroid Minimizing Immunosuppression in Pediatric Kidney Transplant Recipients: A NAPRTCS Study. Pediatr Transplant. 2025 12; 29(8):e70241.
-
Harvey ES, Hamada Y, Hiles SA, Langton D, Thomas D, McDonald VM, Bardin P, Peters M, Reynolds PN, Upham JW, Blakey J, Bowler S, Chien J, Chung LP, Farah CS, Gillman A, Harrington J, Hew M, Jenkins C, Katelaris CH, Katsoulotos GP, Kritikos V, Lee J, Radhakrishna N, Sivakumaran P, Wark PAB, Gibson PG. Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry. Respir Med. 2025 11; 248:108340.
-
Rosas-Salazar C, Gebretsadik T, Seibold MA, Moore CM, Arbes SJ, Bacharier LB, Brunwasser SM, Camargo CA, Dupont WD, Furuta GT, Gruchalla RS, Gupta RS, Jackson DJ, Johnson CC, Kattan M, Khurana Hershey GK, Liu AH, O'Connor GT, Phipatanakul W, Ramratnam SK, Rothenberg ME, Sajuthi SP, Sanders J, Seroogy CM, Snyder BM, Stelzig L, Teach SJ, Zoratti EM, Togias A, Fulkerson PC, Hartert TV. Impact of nasal and inhaled corticosteroids on SARS-CoV-2 infection susceptibility. J Allergy Clin Immunol. 2025 Nov; 156(5):1379-1389.e10.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|